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Background
China embraces the use of risk analysis in the develop-
ment of risk-based approaches for the management of
public health hazards in food safety. Risk analysis is
made up of three components and Figure 1 illustrates
the relationship between the three components of risk
analysis [1]. Estimating the magnitude and distribution
of benefits and costs of particular risk management
options may require addressing a myriad of concerns,
e.g., changes in the availability or nutritional quality of
foods; impacts on consumer confidence in the safety of
the food supply or in the food regulatory system [2].
This is a brief introduction on risk management options
for dealing with the new outcome from risk assessment
approaches in China.
Materials and methods
Traditionally, risk assessment is based on deterministic
endpoints, i.e., use of the no observed (adverse) effect
level (NO(A)EL) and the mean or high level of exposure.
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Figure 1 Food safety risk analysis framework
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In the 21st century, exposure science has increasingly
embraced deterministic models to predict levels of
diverse exposures based on categorical data and on mea-
sured levels of pollutants in biological fluids and tissues.
Increasingly, more probabilistic and distributional meth-
ods are included, to characterize the hazard(s) as well as
the exposure(s). Investigations of total personal exposure
initially employed external measurements of chemicals
that can enter the body, which provide the more prob-
abilistic and distributional methods. These approaches
allow for more description of variability in the population
as well as uncertainty in the risk estimates. Moreover,
additional risk assessment outcomes are being reported,
such as the margin of exposure (MOE), which gives a
relative indication of the level of health concern with
actually quantifying the risk [3-5].
Results
The manner in which health reference guide values
(HBGVs) such as the acceptable, tolerance, and reference
Figure 2 Dietary iodine intake of women and men aged 18 – 50y (excluding outliers) in four coastal provinces in China in 2009, by percentile
and compared to the the Estimated Average Requirement (EAR), the Recommended Dietary Allowance (RDA) and Upper Limit (UL).
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dose (RfD) are estimated usually generates deterministic
values in that they imply a demarcation between what is a
“safe” level of exposure (i.e., exposures below the value)
versus a “non-safe” level (i.e., exposures above the value).
In many instances over the years, these deterministic
values have been used as a common “bright line” approach
to managing risk. Decision makers and competent autho-
rities use these reference values to set standards and regu-
lations for what are appropriate exposures. If uncertainty
and variability be kept in mind, probabilistic modeling
(e.g., with distributions around the values) provides risk
managers more detailed dose response modeling with
greater transparency of the uncertainty surrounding many
of these values. To aid the decision, the risk assessment
should provide information on the nature and magnitude
of uncertainties in both the toxicological and exposure
data that make up the inputs to the distributions being
modeled.
For risk managers, the distribution around the refer-
ence value and its probabilities and uncertainties makes
decision making more complicated, particularly about
who specifically or what portion of a population to pro-
tect. Considerations need to be made regarding whether
the most sensitive individual(s) needs to be protected or
the bulk of the general population (e.g., to decide on a
goal that at least 95 % of any population should not
exceed the acceptable/tolerance intake (in some cases
this could be a long term goal)). For some contaminants,
it may be useful to establish more than one reference
value (e.g., a RfD for the general population and an acute
RfD for pregnant women). The two examples will be
summarized for risk-benefit analysis for universal iodized
salt (figures 2) [6] and maximum limit development of
inorganic arsenic in rice (table 1 and figures 3).
Conclusions
One can imagine a future in which individuals’ expo-
somes are contrasted between diseased and healthy
populations for molecular epidemiology. In either case,
the goal would be to discover causes of ill health and to
generate hypotheses regarding identification and elimina-
tion or reduction of harmful exposures. These expansions
of risk assessment tools and information provided require
additional risk management approaches, included in the
platform to translational toxicology and exposomics.
Acknowledgements
The paper was funded by the National Basic Research Program of China
(973 Program 2012CB720804), National Key Technology R&D Program
(2006BAK02A01 & 2012BAK01B01), and China Ministry of Health (grant
number 200902009).
Published: 17 October 2012
References
1. Abt E, Rodricks J, Levy J, Zeise L, Burke T: Science and decisions:
Advancing risk assessment. Risk Analysis 2010, 30:1028-1036.
2. Carrington C, PM Bolger: The limits of regulatory toxicology. Tox Appl
Pharmacol 2010, 243:191-197.
3. Slob W, MN Pieters: A probabilistic approach for deriving acceptable
human intake limits and human health risks from toxicological studies:
general framework. Risk Analysis 1998, 18:787-798.
4. Lioy P, Rappaport SM: Exposure Science and the Exposome: An
Opportunity for Coherence in the Environmental Health Sciences.
Environ Health Prespect 2012, 119:A466-469.
5. Wild CP: Complementing the genome with an “exposome”: the
outstanding challenge of environmental exposure measurement in
molecular epidemiology. Cancer Epidemiol Biomarkers Prev 2005,
14(8):1847-1850.
6. Wu YN, Li XW, Chang SY, Liu LP, Zou SR, Hipgrave D: Variable iodine
intake persists in the context of universal salt iodization in China. J Nutr
2012.
doi:10.1186/1479-5876-10-S2-A41
Cite this article as: Wu: Translational toxicology and exposomics for
food safety risk management. Journal of Translational Medicine 2012
10(Suppl 2):A41.
Table 1 Diet Exposure for Inorganic Arsenic (iAS) in Rice for various Cluster Diet (g/Kg.bw per day)*
Cluster Diet A B C D E F G H I J K L M
Rice Consumption (g) 91.0 31.6 94.6 33.2 12.7 12.7 376.9 64.3 38.0 74.3 238.4 381.3 34.6
Average iAs Intake 0.17 0.06 0.17 0.06 0.02 0.02 0.69 0.12 0.07 0.14 0.44 0.70 0.06
P90 iAs Intake 0.30 0.11 0.32 0.11 0.04 0.04 1.26 0.21 0.13 0.25 0.79 1.27 0.12
P99 iAs Intake 0.46 0.16 0.47 0.17 0.06 0.06 1.88 0.32 0.19 0.37 1.19 1.91 0.17
Figure 3 The distribution curve of inorganic arsenic concentration
in overall rice samples
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